Edaravone (Radicava®/Radicava ORS®)

( DrugBank: Edaravone / KEGG DRUG: Edaravone )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04259255 (ClinicalTrials.gov)	October 21, 2019	27/1/2020	Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)	Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)	Amyotrophic Lateral Sclerosis;ALS	Drug: Edaravone (Radicava®/Radicava ORS®)	Mitsubishi Tanabe Pharma America Inc.	Massachusetts General Hospital	Recruiting	18 Years	N/A	All	300		United States;Canada

First Previous1Next Last